Posted by Michael Wonder on 10 Nov 2021
SMC accepts oral therapy for relapsing multiple sclerosis
10 November 2021 - Janssen has announced that the SMC have accepted Ponvory (ponesimod) within NHS Scotland, as a treatment for adults with relapsing-remitting multiple sclerosis.
Multiple sclerosis currently affects over 15,000 people in Scotland.
